HPRA v Anne Marie McAleer

The Health Products Regulatory Authority (HPRA)  noted Judge John Brennan’s ruling yesterday at the Dublin District Court in the case brought against Anne Marie McAleer. Ms. McAleer was charged with nine offences relating to importation, supply and placing on the market of the unauthorised medicine, ‘Melanotan II’ and advertisement of Melanotan II and ‘Pinkys Diet Pills’ a second unauthorised medicine. 

The offences took place during 2015 and included the advertising of both unauthorised medicines, on Facebook, on the 8th June and 18th of July 2015.

Ms McAleer pleaded guilty to all nine charges and was fined a total of €4,000.  

According to John Lynch, Director of Compliance, HPRA, “This case involved the importation, supply and advertising of an unauthorised medicine, and the advertising of a second unauthorised medicine, both of which could pose a serious risk to the health of anyone taking them without medical supervision. We continue to warn the public not to buy medicines from unregulated sources. There is no way for consumers to know what substances such products actually contain and consequently they can pose a serious risk to their health. We strongly advise that consumers should only take prescription medicines when prescribed by a doctor and dispensed in a pharmacy. We acknowledge the co-operation of Revenue Customs in this case in detaining, at Portlaoise Mail Centre during July 2015, a quantity of the product ‘Melanotan II’ addressed to Ms McAleer and posted from the USA.”

The HPRA, in conjunction with An Garda Síochána and the Revenue’s Customs Service, continually monitors and investigates instances of illegal supply of medicines and actively enforces against suspected breaches of the law.




Weber Shandwick PR                             (01) 679 8600 

Siobhan Molloy / Rachel Galligan           086 817 5066 / 087 791 9901  




The Health Products Regulatory Authority (HPRA) protects and enhances public health and animal health by regulating medicines, medical devices and other health products. The products under its remit include human and veterinary medicines, medical devices, blood and blood components, tissues and cells, organs for transplantation and cosmetics. Formerly known as the Irish Medicines Board (IMB), it became the Health Products Regulatory Authority on 1 July 2014.


« Back